SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11355119
Source:
http://linkedlifedata.com/resource/pubmed/id/11355119
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021708
,
umls-concept:C0026565
,
umls-concept:C0030705
,
umls-concept:C0041327
,
umls-concept:C0087111
,
umls-concept:C0205082
,
umls-concept:C0205177
,
umls-concept:C0205421
,
umls-concept:C0264490
,
umls-concept:C1880177
pubmed:issue
3
pubmed:dateCreated
2001-5-17
pubmed:abstractText
To clarify the patterns of pulmonary tuberculosis (TB) that should result in a high index of suspicion, to increase the chances of early therapy and to identify predictors of 30-day mortality.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7704851
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0342-4642
pubmed:author
pubmed-author:AzoulayEE
,
pubmed-author:BedosJ PJP
,
pubmed-author:De LassenceAA
,
pubmed-author:KlementEE
,
pubmed-author:LucetJ CJC
,
pubmed-author:RegnierBB
,
pubmed-author:SchlemmerBB
,
pubmed-author:ZaharJ RJR
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
513-20
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11355119-Acute Disease
,
pubmed-meshheading:11355119-Adult
,
pubmed-meshheading:11355119-Antitubercular Agents
,
pubmed-meshheading:11355119-Combined Modality Therapy
,
pubmed-meshheading:11355119-Female
,
pubmed-meshheading:11355119-Hospital Mortality
,
pubmed-meshheading:11355119-Humans
,
pubmed-meshheading:11355119-Intensive Care
,
pubmed-meshheading:11355119-Male
,
pubmed-meshheading:11355119-Middle Aged
,
pubmed-meshheading:11355119-Multiple Organ Failure
,
pubmed-meshheading:11355119-Predictive Value of Tests
,
pubmed-meshheading:11355119-Prognosis
,
pubmed-meshheading:11355119-Respiration, Artificial
,
pubmed-meshheading:11355119-Respiratory Insufficiency
,
pubmed-meshheading:11355119-Retrospective Studies
,
pubmed-meshheading:11355119-Risk Factors
,
pubmed-meshheading:11355119-Serum Albumin
,
pubmed-meshheading:11355119-Survival Analysis
,
pubmed-meshheading:11355119-Time Factors
,
pubmed-meshheading:11355119-Treatment Outcome
,
pubmed-meshheading:11355119-Tuberculosis, Pulmonary
pubmed:year
2001
pubmed:articleTitle
Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure.
pubmed:affiliation
Intensive Care Department, Bichat Claude-Bernard Hospital, University Paris 7, 46 rue Henri Huchard, 75018 Paris, France. JRZahar@hotmail.com
pubmed:publicationType
Journal Article